Identification of Persuasive Antiviral Natural Compounds for COVID-19 by Targeting Endoribonuclease NSP15: A Structural-Bioinformatics Approach

被引:15
|
作者
Saeed, Mohd [1 ]
Saeed, Amir [2 ]
Alam, Md Jahoor [1 ]
Alreshidi, Mousa [1 ]
机构
[1] Univ Hail, Coll Sci, Dept Biol, Hail 2440, Saudi Arabia
[2] Univ Hail, Coll Appl Med Sci, Dept Clin Lab Sci, Hail 2440, Saudi Arabia
来源
MOLECULES | 2020年 / 25卷 / 23期
关键词
SARS-CoV-2; NSP15; virtual screening; molecular dynamics; natural compounds; MOLECULAR-DYNAMICS; HIGH-THROUGHPUT; DRUG DISCOVERY; SOLUBILITY; PREDICTION; INHIBITORS; GROMACS; EVASION; TOOL;
D O I
10.3390/molecules25235657
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
SARS-CoV-2 is a positive-stranded RNA virus that bundles its genomic material as messenger-sense RNA in infectious virions and replicates these genomes through RNA intermediates. Several virus-encoded nonstructural proteins play a key role during the viral life cycle. Endoribonuclease NSP15 is vital for the replication and life cycle of the virus, and is thus considered a compelling druggable target. Here, we performed a combination of multiscoring virtual screening and molecular docking of a library of 1624 natural compounds (Nuclei of Bioassays, Ecophysiology and Biosynthesis of Natural Products (NuBBE) database) on the active sites of NSP15 (PDB:6VWW). After sequential high-throughput screening by LibDock and GOLD, docking optimization by CDOCKER, and final scoring by calculating binding energies, top-ranked compounds NuBBE-1970 and NuBBE-242 were further investigated via an indepth molecular-docking and molecular-dynamics simulation of 60 ns, which revealed that the binding of these two compounds with active site residues of NSP15 was sufficiently strong and stable. The findings strongly suggest that further optimization and clinical investigations of these potent compounds may lead to effective SARS-CoV-2 treatment.
引用
收藏
页数:16
相关论文
共 41 条
  • [1] Selection of Active Antiviral Compounds Against COVID-19 Disease Targeting Coronavirus Endoribonuclease Nendou/NSP15 Via Ligand-based Virtual Screening and Molecular Docking
    Joshi, Gaurav
    Poduri, Ramarao
    LETTERS IN DRUG DESIGN & DISCOVERY, 2021, 18 (06) : 610 - 619
  • [2] Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease
    Canal, Berta
    Fujisawa, Ryo
    McClure, Allison W.
    Deegan, Tom D.
    Wu, Mary
    Ulferts, Rachel
    Weissmann, Florian
    Drury, Lucy S.
    Bertolin, Agustina P.
    Zeng, Jingkun
    Beale, Rupert
    Howell, Michael
    Labib, Karim
    Diffley, John F. X.
    BIOCHEMICAL JOURNAL, 2021, 478 (01) : 2465 - 2479
  • [3] Pharmacoinformatics approach based identification of potential Nsp15 endoribonuclease modulators for SARS-CoV-2 inhibition
    Savale, Rutuja Umesh
    Bhowmick, Shovonlal
    Osman, Sameh Mohamed
    Alasmary, Fatmah Ali
    Almutairi, Tahani Mazyad
    Abdullah, Dalal Saied
    Patil, Pritee Chunarkar
    Islam, Md Ataul
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2021, 700
  • [4] Vitamin D is a potential inhibitor of COVID-19: In silico molecular docking to the binding site of SARS-CoV-2 endoribonuclease Nsp15
    Shalayel, Mohammed H.
    Al-Mazaideh, Ghassab M.
    Aladadeh, Saleem H.
    Al-Swailmi, Farhan K.
    Al-Thiabat, Mohammad G.
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 33 (05) : 2179 - 2186
  • [5] Analysis of natural compounds against the activity of SARS-CoV-2 NSP15 protein towards an effective treatment against COVID-19: a theoretical and computational biology approach
    Olaa Motwalli
    Meshari Alazmi
    Journal of Molecular Modeling, 2021, 27
  • [6] Analysis of natural compounds against the activity of SARS-CoV-2 NSP15 protein towards an effective treatment against COVID-19: a theoretical and computational biology approach
    Motwalli, Olaa
    Alazmi, Meshari
    JOURNAL OF MOLECULAR MODELING, 2021, 27 (06)
  • [7] A multilevel approach for screening natural compounds as an antiviral agent for COVID-19
    Vasighi, Mahdi
    Romanova, Julia
    Nedyalkova, Miroslava
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2022, 98
  • [8] Identification of daclatasvir as a repurposed drug against Nsp15 of SASR-CoV2 (COVID-19) by using in silico approaches
    Jha, Prakash
    Chopra, Madhu
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 58 : 39 - 39
  • [9] Natural Compounds for COVID-19 Antiviral Drug Discovery
    Thomford, Nicholas Ekow
    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2022, 26 (10) : 580 - 581
  • [10] Drug repositioning to target NSP15 protein on SARS-CoV-2 as possible COVID-19 treatment
    Sixto-Lopez, Yudibeth
    Martinez-Archundia, Marlet
    JOURNAL OF COMPUTATIONAL CHEMISTRY, 2021, 42 (13) : 897 - 907